Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buspirone for Stress and Attentional Bias in Marijuana Use
NCT02132832Phase 2Completed
- Sponsor
- UTHealth Houston
- Start
- Jun 2013
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of buspirone in cannabis use disorder (CUD), sponsored by UTHealth Houston. Started Jun 2013; status: completed.
02
Drugs
buspirone
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT02132832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02132832.